Recent Finacing
Recent Raise
Proteon Therapeutics develops PRT-201, a locally-acting recombinant human elastase intended to dilate arteries and veins and reduce neointimal hyperplasia to improve hemodialysis vascular access patency.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
